Partnerships


Collaborations are the cornerstone of the IGNITE project’s success. Sharing information, expertise and effort enables faster and more readily –validated results.

Corporate Partners

Our expertise can bring us to the brink of pharmaceutical development – the genetic links behind orphan diseases, the potential targets for therapeutic intervention, and the compounds best suited for pharmaceutical development.

But we need strategic, forward-thinking commercial partners to take it to the next level.

Specifically, we are looking for partners who can optimize promising compounds, conduct clinical trials and collaborate on other important aspects of the drug development process.

If you are interested in this kind of pharmaceutical development partnership, please contact us. In turn, if you are a commercial entity, interested in a particular disease, please see below.

We are also looking to add more compounds to our screening process, which will increase the odds of finding potential therapeutics for specific diseases. If you have compound libraries that you are interested in sharing for the study of one or more diseases, please contact us

Research Partners

The IGNITE project’s unique and extensive experience with orphan diseases allows us to provide partnering opportunities to entities who are interested in the development of diagnostics and/or drug treatments for similar diseases.

Some orphan diseases can inform the treatment of common, high-impact disorders such as cancer, diabetes and hypertension. The IGNITE project’s unique and extensive experience enables us to provide partnering opportunities to groups who are interested in the development of diagnostics and/or drug treatments for common diseases that share features with much rarer entities.

If you have a specific disease, condition or phenotype under evaluation, we would be happy to hear from you, and to determine if there is a way we can use our platform to collaborate.

In turn, we are always looking for partners to help us fulfill our mandate of finding the genetic basis and potential treatment for the orphan diseases listed here.